Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

BENZOCAINE AND MENTHOL

Active
SPE2DP-26-T-4247Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

BLDG 5505A WICKHAM AVE, FORT CAMPBELL, KY, 42223-5000, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4247.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS

Full Description

Show more
BENZOCAINE AND MENTHOL LOZENGE
Benzocaine and Menthol Lozenge CEPACOL EXTRA STRENGTH SORE THROAT HONEY LEMON LOZENGES. BENZOCAINE 15MG, MENTHOL 2.6MG ORAL PAIN RELIEVERS, PACKAGE OF 16. STORE AT 20-25 C (68-77 F).PROTECT CONTENTS FROM HUMIDITY.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
RECKITT BENCKISER LLC 0MWS8 P/N NDC638240732-16 RB HEALTH US LLC 860J1 P/N NDC63824-0732-16
SPE2DP-26-T-4247
SECTION B
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017584870 0001 PG 2.000
NSN/MATERIAL:6505017081449
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4247
SECTION B
PR: 7017584870 PRLI: 0001 CONT’D
BULK BREAK POINT:
W34GMT
0129 CS BN CO A COMPOSITE
AWCF SSF
BLDG 5505A WICKHAM AVE
FORT CAMPBELL KY 42223-5000
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W34GMT
0129 CS BN CO A COMPOSITE
AWCF SSF
BLDG 5505A WICKHAM AVE
FORT CAMPBELL KY 42223-5000
US
MARKFOR
W34GMT
0129 CS BN CO A COMPOSITE
AWCF SSF
BLDG 5505A WICKHAM AVE
FORT CAMPBELL KY 42223-5000
US
M/F: (TCN) W34GMT62020282
RDD: 217
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:07/27/2026
SPE2DP-26-T-4247 NSN/Part Number: 6505-01-708-1449 Quantity: 2 PG Purchase Request: 7017584870QTY: 2 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
DIBBS
PSYLLIUM HYDROPHILIThe contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12 gram packets, each containing 25 mg potassium and 5 mg sodium, packaged in units of 30 packets per package, with a total requirement of 19,000 packets across multiple CLINs. The item is regulated by the FDA and must be supplied with the manufacturer’s part number NDC37000-0740-87 under The Procter & Gamble Distributing LLC. The product has a non-extendable shelf life of 24 months, and all packaging must comply with the latest Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be labeled in accordance with DLA packaging requirements. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport by common carrier at the lowest cost. Delivery is FOB destination with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The contract requires precise marking, palletization, and traceable shipping methods, explicitly prohibiting parcel post. Delivery schedules vary by CLIN and are set between June 2025 and July 2026, with fulfillment addressed to multiple DoD locations including Camp Pendleton, Camp Kinsler, and the USS Pinckney. Bidders must specify their source and part number, and the contracting officer must refer the bid to a product specialist for FDA-regulated item confirmation. Technical and quality requirements are governed by the DLA Master List, and all documentation must align with the version in effect on the solicitation or award date.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
PSYLLIUM HYDROPHILIC MThe contract is for Psyllium Hydrophilic Mucilloid in sugar orange flavor, supplied in 12 gm packets, with each packet containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per box. The item is regulated by the FDA and must be procured with the specified manufacturer part number NDC37000-0740-87 from The Procter & Gamble Distributing LLC. It carries a non-extendable 24-month shelf life under Type I (Code M) requirements and must be packaged and marked in strict accordance with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet DLA requirements, including commercial-grade sealed unit containers and shipping containers that ensure safe delivery at the lowest possible rate. The unit of issue is a package of 30s, with a total quantity of 4 packages required. Delivery is FOB destination within 20 days, with zero variance permitted, and inspection and acceptance occur at the delivery point. The shipment is designated for a military vessel, with specific transportation protocols requiring the use of traceable methods and prohibiting parcel post. All labeling, packing, and marking must comply with applicable DLA standards, and bidders must clearly state the source and part number. The contract is issued under solicitation SPE2DP-26-T-4220 with an original delivery deadline of July 23, 2026, and is managed by the Department of Defense’s Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
VERAPAMIL HYDROCHLORIDVerapamil hydrochloride injection is a 5 mg per 2 mL (2.5 mg/mL) preservative-free, single-dose solution supplied in 2 mL glass flip-top vials, with a package quantity of 25 vials per unit. The product is intended solely for intravenous use and must be protected from light during storage and handling. It should be stored at a controlled room temperature of 20 to 25°C (68 to 77°F) in accordance with USP standards. The item has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The NSN is 6505-01-738-0226, and the purchase request number is 7017548722 with a delivery requirement of five days after order award. The contract is issued under solicitation number SPE2DP-26-T-4217, posted on July 21, 2026, with a response deadline of July 27, 2026. The NAICS code is 325411, and the contracting agency is the Department of Defense through the Medical Supply Chain Pharmaceutical FSA. Delivery is to Joint Base Elmendorf-Richardson in Alaska, 99506-4400. The contract incorporates technical and quality requirements from the DLA Master List and applies DLA packaging standards. Covered defense information may apply, and federal regulations require removal of government identification from non-accepted supplies. Primary point of contact is Daniel Porter, reachable by phone or email as listed.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100 mg, in bottles of nine tablets, are procured for the acute treatment of migraine with or without aura in adults, with storage requirements between 20 to 25°C (68 to 77°F) and protection from light. The product has a non-extendable 24-month shelf life as a Type I (Code M) item and must be marked in compliance with the latest Medical Marking Standard No. 1 and MIL-STD-129, with packaging governed by MIL-STD-2073-1E and DLA’s Packaging Requirements for Procurement. Two delivery lines are specified: one for two bottles to Fort Stewart, Georgia, and another for one bottle to Joint Base Elmendorf-Richardson, Alaska, both with a five-day delivery window and FOB destination terms, zero quantity variance, and inspection and acceptance occurring at the delivery point. The item is regulated by the FDA, and bidders must provide manufacturer details, including NDC numbers for Mylan Pharmaceuticals Inc and Golden State Medical Supply, Inc., along with required documentation referenced from the DLA Master List of Technical and Quality Requirements. The solicitation, issued under SPE2DP-26-T-4216 by the Department of Defense, requires shipment via traceable means only, prohibits parcel post, and includes federal-specific codes for distribution, tracking, and government use. The original required delivery dates are July 22 and July 23, 2026, with the solicitation closing on July 27, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection is a sterile, nonpyrogenic intravenous solution designated for fluid and electrolyte replenishment, serving as a source of water and essential electrolytes. It contains no antimicrobial agents and is supplied in single-dose containers, intended for medical use under strict aseptic conditions. The product must comply with stringent packaging and marking requirements per Medical Marking Standard No. 1, superseding MIL-STD-129, and must be labeled in accordance with SPE2DP-26-T-4198. Each unit must be sealed in protective packaging to prevent damage or breakage and packed in commercial shipping containers suitable for safe transport at the lowest carrier rate to the delivery point. The product must be stored in moisture barrier overwrap at room temperature (25°C/77°F), avoiding excessive heat, and must maintain a shelf life of 15 months with no more than two months elapsed between manufacture and government delivery. It is manufactured by Baxter Healthcare Corporation under part number 2B1313Q and identified by NSN 6505014622120, with a unit of issue of PG. The contract specifies a single unit quantity of one PG to be delivered within 20 days FOB destination, with zero variance permitted in quantity and inspection and acceptance occurring at the point of delivery. The solicitation under number SPE2DP-26-T-4198, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, requires compliance with the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on acquisition size. The product must be procured under the DoD authorized unit of issue, referenced via official DLA documentation. All documentation, including marking and packaging, must strictly adhere to current DLA standards, and technical specifications are incorporated by reference. The point of contact is Meghan Smink, with the place of performance identified as Sea Girt, NJ, 08750-0000, and the response deadline for bids closing in July 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
SKIN PROTECTIVE OINThe contract specifies the procurement of 3M CAVILON DURABLE BARRIER CREAM 3355, a concentrated, pH-balanced, waterproof skin protective ointment formulated with 3M polymer technology to resist wash-off and enhance adhesive adherence while moisturizing skin and safeguarding against bodily fluids. Each unit is a 3.25-ounce (92 g) tube, sold in a case of twelve, and must be stored at room temperature between 68°F and 77°F (20°C to 25°C), with temporary excursions allowed between 59°F and 86°F (15°C to 30°C). The product has a non-extendable shelf life of 24 months under the RS016 requirement for a Type I code M item. The specification incorporates technical and quality standards from the DLA Master List of Technical and Quality Requirements, with compliance tied to the master list revision effective on the solicitation or award date. Packaging must meet DLA procurement standards, and government identification must be removed from non-accepted supplies. Covered defense information may apply, and bidders are required to clearly state the source and part number being supplied. The NSN is 6505-01-727-6854, with a single case order quantity under purchase request 7017546881, and delivery is required within 20 days of order award. The solicitation, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, has a response deadline of July 27, 2026, and is cataloged under NAICS code 325411 with performance at Nellis AFB, Nevada.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMIErythromycin Ophthalmic Ointment, USP, is a sterile topical medication containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, formulated for ophthalmic use as an RX-only product. Each unit is packaged in single-dose tubes containing 3.5 grams of ointment, with a unit of issue consisting of 24 tubes per package. The product has a total shelf life of 36 months, and upon receipt by the first government activity, it must have a minimum of 31 months of remaining shelf life. Storage requirements specify controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and commercial packaging must comply with ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements. The manufacturer is PADAGIS US LLC with NDC 00574-4024-39, and the NSN is 6505-01-189-7090. The contract requires delivery of one package (24 tubes) to Fort Bragg, North Carolina, within 20 days of issuance, with FOB destination and zero tolerance for quantity variance. Delivery must be made via traceable freight methods, excluding parcel post, and packaging must meet all DLA procurement standards including palletization and hazardous material handling per FED-STD-313 where applicable. The item falls under a Type I (Code Q) shelf-life category with a non-extendable 36-month lifespan. The contracting official must submit a referral via EBS to confirm product compliance with FDA regulations, including manufacturer and part number details. The solicitation, issued under SPE2DP-26-T-4260, was posted on July 23, 2026, with a response deadline of July 29, 2026, and the required delivery date is July 14, 2026. All documentation, labeling, and marking must align with DLA’s current technical and quality requirements, and the point of contact for inquiries is James McCullough.
Pharmaceutical Preparation Manufacturing

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
LORATADINE TABLETSLoratadine tablets 10 mg are being procured in quantities of 2 business units, with each unit containing 500 tablets, for a total of 1,000 tablets under contract SPE2DP-26-T-4248. The product must comply with all technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements, including packaging and marking standards specified in Medical Marking Standard No. 1, which replaces MIL-STD-129. Packaging must be commercial-grade, with each unit sealed in a container that protects against damage and breakage, and shipped in exterior containers suitable for safe delivery via common carrier at the lowest cost to the destination point. The item is regulated by the FDA and requires storage between 20°C and 25°C (68°F to 77°F), protected from excessive moisture. It has a non-extendable shelf life of 36 months, classified as a TYPE I (CODE Q) item under DLA shelf-life requirements. The manufacturer is OHM Laboratories Inc. with NDC 51660-0526-05, and the distributor is AmerisourceBergen Drug Corp. Delivery is FOB destination within 20 days of contract award with zero tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The NSN is 6505-01-524-9179, and all markings must adhere to the latest MMS No. 1 guidelines available through DLA Troop Support. The contracting official must submit a referral in EBS with manufacturer and bidder details prior to award.
Pharmaceutical Preparation Manufacturing

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 423450
New
DIBBS
OMEPRAZOLE EXTENDED-REThe contract specifies the procurement of 20 mg omeprazole extended-release capsules in 90-count bottles, identified by NSN 6505016247068 and NDC 00781-2868-92, manufactured by Sandoz Inc. Each unit must be packaged in sealed commercial containers that protect against damage, with shipping containers meeting commercial standards for safe delivery at the lowest freight rate. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must adhere to DLA’s Packaging Requirements. The product has a 24-month shelf life, with at least 21 months remaining at the time of delivery to the first government activity. All units are subject to strict DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951, and must be shipped via the fastest traceable means—parcel post is prohibited. The drug is FDA-regulated, and bidders must be referred for product specialist confirmation. Deliveries are split across multiple locations including Fort Stewart, Georgia and Fort Campbell, Kentucky, with rigid zero variance in quantity and fixed delivery dates in July 2026. Inspection and acceptance occur at destination, with all markings and documentation required to align with government-specific identifiers and freight instructions provided in full detail for each delivery point.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LACRINGER'S INJECTION LACTATED USP in 1000 mL units, packaged 12 per pack (1 PG), is procured under contract SPE2DP-26-T-4258 with a total quantity of 21 packs to be delivered within 20 days FOB destination. The product is regulated by the FDA and carries a non-extendable shelf life of 30 months as a TYPE I (CODE P) item. Packaging must comply with Medical Marking Standard No. 1, replacing all prior references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Units must be packed in commercial exterior shipping containers suitable for safe delivery at the lowest carrier rate, with labeling and marking strictly following the latest version of MMS No. 1. The product must be stored at room temperature (25°C), with brief exposure up to 40°C permitted without adverse effects, and must be protected from freezing and excessive heat. The manufacturer is B. BROWN MEDICAL INC with NDC number 00264-7750-00 and part number L7500. Inspection and acceptance occur at the delivery point with zero variance allowed in quantity. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with applicable revisions controlled by the solicitation or award date. Government identification must be removed from non-accepted supplies per RQ011, and procurement is subject to covered defense information provisions. Delivery is to Fort Bragg, NC, with primary point of contact Timothy McCauley at DLA.
Pharmaceutical Preparation Manufacturing

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
IOHEXOL INJECTIONIOHEXOL INJECTION, USP at 300 mg per milliliter in 150 mL polymer bottles, is being procured in boxes of ten bottles each, with a total quantity of 24 boxes required under contract SPE2DP-26-T-4252. The product is classified as a radiological contrast media and must be stored at controlled room temperature between 20–25°C (68–77°F), with excursions permitted between 15–30°C (59–86°F), and must be protected from strong daylight and direct sunlight and not frozen. It carries a non-extendable shelf life of 36 months and must be packaged and marked in accordance with Medical Marking Standard No. 1, superseding MIL-STD-129. Each unit must be sealed and protected against damage, and shipped in commercial exterior containers suitable for safe transport via common carrier at the lowest cost to the designated delivery point at Fort Bragg, North Carolina. The item is subject to Hazard Communication Standard requirements, necessitating Safety Data Sheets aligned with 29 C.F.R. 1910.1200 and compliant labeling prior to award, along with employee training on the updated standards. Packaging must conform to DLA’s RP001 requirements and federal hazardous material guidelines, and if classified as hazardous under Fed-Std-313, must follow TQ requirement IP025; otherwise, commercial packaging per ASTM D3951 applies, though DLA’s technical requirements take precedence. Delivery is required within five days of order placement, FOB destination, with no variance allowed in quantity. The product is supplied by GE HEALTHCARE INC, identified by NDC 00407-1413-65, and must be shipped by the fastest traceable means, excluding parcel post. The required delivery date is July 24, 2026, with solicitation responses due by July 29, 2026.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details